A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis

Andrew Volk, Kaiwei Liang, Praveen Suraneni, Xinyu Li, Jianyun Zhao, Marinka Bulic, Stacy Marshall, Kirthi Pulakanti, Sebastien Malinge, Jeffrey Taub, Yubin Ge, Sridhar Rao, Elizabeth Bartom, Ali Shilatifard, John D. Crispino*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

60 Scopus citations

Abstract

CHAF1B is the p60 subunit of the chromatin assembly factor (CAF1) complex, which is responsible for assembly of histones H3.1/H4 heterodimers at the replication fork during S phase. Here we report that CHAF1B is required for normal hematopoiesis while its overexpression promotes leukemia. CHAF1B has a pro-leukemia effect by binding chromatin at discrete sites and interfering with occupancy of transcription factors that promote myeloid differentiation, such as CEBPA. Reducing Chaf1b activity by either heterozygous deletion or overexpression of a CAF1 dominant negative allele is sufficient to suppress leukemogenesis in vivo without impairing normal hematopoiesis. Volk et al. show that overexpression of the chromatin assembly factor complex subunit CHAF1B promotes leukemogenesis by interfering with chromatin occupancy of transcription factors that promote myeloid differentiation. Reducing CHAF1B activity suppresses leukemogenesis without impairing normal hematopoiesis.

Original languageEnglish (US)
Pages (from-to)707-723.e7
JournalCancer cell
Volume34
Issue number5
DOIs
StatePublished - Nov 12 2018

Funding

The authors thank Gina Kirsammer and Christian Marinaccio for advice, and Peter Adams and Jiwang Zhang for providing critical reagents. The authors also would like to thank Guy Savageau for the Leucegene data and consultation regarding the expression of CHAF1A and CHAF1B. This study was supported by the Samuel Waxman Cancer Research Foundation (to J.D.C.) and the NIH (R01 CA101774 to J.D.C.; T32 CA080621 to A.V.). A.V. is supported by a Scholar Award from American Society of Hematology. Leukemia studies in the Shilatifard laboratory are supported by NCI R35 CA197569. E.B. is supported by R50 CA221848. This research was also supported by the Lurie Cancer Center. This work was supported by the Northwestern University Pathology Core and Flow Cytometry Facilities, funded by CCSG NCI CA060553, and cell sorting was performed on a BD FACSAria SORP system purchased with the support of NIH 1S10OD011996-01. The authors thank Gina Kirsammer and Christian Marinaccio for advice, and Peter Adams and Jiwang Zhang for providing critical reagents. The authors also would like to thank Guy Savageau for the Leucegene data and consultation regarding the expression of CHAF1A and CHAF1B. This study was supported by the Samuel Waxman Cancer Research Foundation (to J.D.C.) and the NIH ( R01 CA101774 to J.D.C.; T32 CA080621 to A.V.). A.V. is supported by a Scholar Award from American Society of Hematology. Leukemia studies in the Shilatifard laboratory are supported by NCI R35 CA197569 . E.B. is supported by R50 CA221848 . This research was also supported by the Lurie Cancer Center . This work was supported by the Northwestern University Pathology Core and Flow Cytometry Facilities, funded by CCSG NCI CA060553 , and cell sorting was performed on a BD FACSAria SORP system purchased with the support of NIH 1S10OD011996-01 .

Keywords

  • CAF1
  • CHAF1B
  • MLL-AF9
  • hematopoiesis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis'. Together they form a unique fingerprint.

Cite this